Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$355M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$304M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$267M |
| 4 |
Gilead Sciences
GILD
|
+$239M |
| 5 |
Visa
V
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$388M |
| 2 |
Wells Fargo
WFC
|
+$370M |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$295M |
| 4 |
Alibaba
BABA
|
+$234M |
| 5 |
IBM
IBM
|
+$210M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.55% |
| 2 | Healthcare | 5.29% |
| 3 | Financials | 4.23% |
| 4 | Communication Services | 3.53% |
| 5 | Energy | 2.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAGE
4426
DELISTED
Sage Therapeutics
SAGE
| $77K | ﹤0.01% |
2,394
+1,823
| +319% | +$64.2K |
|
4427
Unilever
UL
$135B
| $77K | ﹤0.01% |
1,517
-87
| -5% | -$4.23K |
|
|
FLIR
4428
PUT
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $77K | ﹤0.01% |
2,400
+2,200
| +1,100% | +$67.9K |
|
|
MYOK
4429
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $77K | ﹤0.01% |
7,698
+7,563
| +5,602% | +$68.8K |
|
|
DNR
4430
CALL
DELISTED
Denbury Resources, Inc.
DNR
| $77K | ﹤0.01% |
38,500
+18,300
| +91% | +$30.5K |
|
|
ALX
4431
Alexander's
ALX
$1.38B
| $76K | ﹤0.01% |
198
+37
| +23% | +$14K |
|
|
CLDT
4432
Chatham Lodging
CLDT
$580M
| $76K | ﹤0.01% |
3,616
-1,699
| -32% | -$33.8K |
|
4433
The GEO Group
GEO
$4.04B
| $76K | ﹤0.01% |
3,344
-135
| -4% | -$2.64K |
|
|
PRO
4434
DELISTED
PROS Holdings
PRO
| $76K | ﹤0.01% |
6,967
+6,868
| +6,937% | +$88.5K |
|
|
RDUS
4435
DELISTED
Radius Recycling
RDUS
| $76K | ﹤0.01% |
4,276
+3,553
| +491% | +$52.5K |
|
4436
Washington Trust Bancorp
WASH
$735M
| $76K | ﹤0.01% |
+2,072
| New | +$77.4K |
|
|
ARNA
4437
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $76K | ﹤0.01% |
7,612
-15,641
| -67% | -$251K |
|
|
AMAG
4438
CALL
DELISTED
AMAG Pharmaceuticals
AMAG
| $76K | ﹤0.01% |
3,300
+2,200
| +200% | +$52.2K |
|
|
EMES
4439
CALL
DELISTED
Emerge Energy Services LP
EMES
| $76K | ﹤0.01% |
19,100
-41,800
| -69% | -$170K |
|
|
SGI
4440
DELISTED
Silicon Graphics Intl.
SGI
| $76K | ﹤0.01% |
+10,800
| New | +$65.9K |
|
4441
Kirby Corp
KEX
$7B
| $75K | ﹤0.01% |
1,252
-687
| -35% | -$37.5K |
|
4442
CALL
Olin
OLN
$2.15B
| $75K | ﹤0.01% |
4,400
+2,400
| +120% | +$37.1K |
|
4443
CALL
Wendy's
WEN
$1.39B
| $75K | ﹤0.01% |
7,500
-22,500
| -75% | -$223K |
|
|
SSRI
4444
DELISTED
Silver Standard Resources
SSRI
| $75K | ﹤0.01% |
14,996
+3,921
| +35% | +$20.7K |
|
4445
American Superconductor
AMSC
$1.5B
| $74K | ﹤0.01% |
+10,533
| New | +$70.5K |
|
4446
PUT
Invesco DB Agriculture Fund
DBA
$1.24B
| $74K | ﹤0.01% |
3,700
-49,200
| -93% | -$996K |
|
4447
CALL
Invesco DB Precious Metals Fund
DBP
$259M
| $74K | ﹤0.01% |
+2,000
| New | +$71.6K |
|
4448
CALL
MBIA
MBI
$256M
| $74K | ﹤0.01% |
9,300
-13,500
| -59% | -$98.3K |
|
4449
Sunrun
RUN
$2.38B
| $74K | ﹤0.01% |
12,327
+6,947
| +129% | +$49.9K |
|
4450
Universal Insurance Holdings
UVE
$1.21B
| $74K | ﹤0.01% |
4,294
-70,908
| -94% | -$1.31M |
|
Similar funds
Barclays's Q1 2016 Portfolio in Review
As of Q1 2016, Barclays held 6,944 positions worth $65.6B, down 20% from $82.3B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays withdrew a net $15.2B in Q1 2016, closing 588 positions and reducing 2,924 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $295M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 4.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR S&P Pharmaceuticals ETF worth $26M.
- Barclays's largest Q1 2016 buy was State Street SPDR S&P Pharmaceuticals ETF: 650,000 shares worth $26M.
- Barclays added most to KLA in Q1 2016, an estimated $355M increase.
- Barclays's biggest Q1 2016 reduction was Apple, cutting an estimated $388M.
- Barclays fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $295M.
- Barclays's ten largest holdings make up 29% of its $65.6B portfolio in Q1 2016.
- Barclays opened 766 new positions and closed 588 in Q1 2016.
- Barclays's portfolio value fell 20% quarter-over-quarter to $65.6B.
Based on Barclays's 13F filing for Q1 2016, filed 16 May 2016.